ArticleBMC public health2025
Trends and determinants of female genital mutilation prevalence among women of reproductive age in Tanzania and Kenya: a demographic and health survey analysis (2008-2022).
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundFemale genital mutilation (FGM) remains a critical global public health challenge, with over 230 million affected women and girls, predominantly in Sub-Saharan Africa. Despite the reduction in FGM in both countries, the proportion of women who had FGM are still considerably high. Therefore, the study seeks to examine the socio-economic/demographic determinants of FGM in Kenya and Tanzania to inform more targeted interventions.
methodsA retrospective analysis of Demographic and Health Survey (DHS) data from 6,517 women aged 15-49 in Kenya and Tanzania (2008-2022) was conducted. Trends were assessed using weighted prevalence percentages and visualized via line graphs. Chi-square tests and multivariable logistic regression, adjusting for complex survey design, identified associations between FGM and socio-demographic, economic, and media-related determinants.
resultsHigher education (AOR = 0.25, p < 0.001), wealth (AOR = 0.62, p < 0.002), urban residence (AOR = 0.37, p < 0.001), and weekly radio exposure (AOR = 0.53, p < 0.001) significantly reduced FGM risks. Conversely, rural residence (AOR = 4.12, p < 0.001), religious mandates (AOR = 3.81, p < 0.001), and recent internet use (AOR = 2.40, p < 0.001) increased vulnerability. Contextual disparities emerged: Kenya's FGM was strongly associated with Muslim affiliation (AOR = 9.41, p < 0.001), while Tanzania's persistence stemmed from rural agrarian livelihoods and occupational inequities. Internet use paradoxically correlated with higher FGM prevalence, reflecting potential urban-rural divides in digital health messaging efficacy.
conclusionEducation, economic stability, urban living, literacy, and radio exposure lower FGM risks in Kenya and Tanzania, while rural poverty, limited education, religious justifications, and internet use increase them. FGM in Kenya is linked to Muslim practices, requiring faith-sensitive strategies, while in Tanzania, it is tied to rural ethnic traditions. Interestingly, higher internet use correlates with increased FGM prevalence, suggesting it may perpetuate harmful norms without targeted messaging. Effective interventions should integrate legal enforcement, community education, women's empowerment, and cultural partnerships, extending urban strategies to rural areas and combating misinformation through digital literacy. Limitations like cross-sectional design highlight the need for longitudinal research. Ongoing, context-driven efforts are crucial for eliminating FGM and advancing global gender equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.